Big Pharma Stocks NOSEDIVE After RFK Jr. Appointed HHS Secretary

It’s clear that Big Pharma is feeling the heat as Robert F. Kennedy Jr. steps up to challenge their grip on America!

The moment he was nominated by Donald Trump to serve as the Secretary of Health and Human Services, stocks took a nosedive: Moderna plummeted 6% and Pfizer fell 2.6%. This reaction speaks volumes about the fear these pharmaceutical giants have of someone finally standing up for the American people.

Kennedy has made it his mission to confront Big Pharma and the food industry, which have been poisoning Americans for far too long. As he rightly points out, “It’s no coincidence that Americans die earlier than Canadians, or Germans, or Italians, or Japanese, or Koreans, or Australians…” The evidence is clear: “Suddenly, more and more Americans began suffering from chronic diseases…”

JUST IN: Big Pharma stocks tank just moments after Robert F. Kennedy Jr. was nominated to be Donald Trump's Department of Health and Human Services secretary.

Moderna: Down 6%
Pfizer: Down 2.6%

Why? RFK has vowed to take on Big Pharma as well as the food industry for… pic.twitter.com/9LtRBpIgVs

— Collin Rugg (@CollinRugg) November 14, 2024

Kennedy teaming up with Trump was the twist we never saw coming and absolutely won over parents in large, especially mothers. We voted for the candidates who are not only going to make our food affordable again, but they are going to hold these companies responsible for the toxins they are allowing into our products!!

The Democrats have allowed this travesty to continue unchecked, but with RFK’s nomination as HHS secretary, there’s hope for change. Big Pharma has been raking in billions by selling drugs like Adderall and Prozac while leaving Americans unhealthy and dependent. As Kennedy says, “Enough is enough.” It’s time for Republicans to take a stand and put an end to this exploitation.